A potential drug for malaria?
An international collaboration of chemists have synthesised an o-quinodimethane that reacts with triplet oxygen to form a stable endoperoxide. o-quinodimethanes (o-xylylenes) have attracted great interest as they are useful building blocks for a variety of polycyclic compounds, that often exhibit biological activity. This has lead to increased activity from chemists interested in determining whether o-quinodimethanes are diradical or tetraene species.

Heinz Gornitzka, Jean Escudié and colleagues from the University of Toulouse, France, in partnership with researchers at the Sidi Mohamed Ben Abdellah University, Morocco and collaborators at the University of California, have synthesised a stable substituted o-quinodimethane by a one-step procedure, from a germene and 1,4-naphthoquinone. Gornitzka and his team go on to show the great reactivity of the o-quinodimethane by reacting it with triplet oxygen to form an endoperoxide.
Gornitzka believes that this approach will lead to a generalisation of the reaction -changing the substituents on germanium and on the starting materials to determine the factors that affect the stabilisation of o-quinodimethane species. ‘We also plan to perform the synthesis of such derivatives from other doubly bonded compounds, for example >Si=C< to determine the influence of a heavier element on the stability and reactivity,’ he says.
Gornitzka hopes to probe the potential biological activity of the endoperoxide obtained from the reaction of the quinodimethane and oxygen, as most active drugs for the treatment of malaria present an endoperoxide structure. ‘We will extend the biological screening to other endoperoxides, to try to understand the relationship between structure and activity, in order to synthesise the most active compound,’ he adds.
Original publication: Ghereg et. al., Chem. Commun., 2009.
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.